Sublingual misoprostol allergy: A case report
Nigerian Journal of Medicine, 2019 Misoprostol is being used in obstetrics especially during the first and third trimesters of pregnancy. It has become a good drug for prevention and treatment of postpartum haemorrhage. It is considered a safe drug with few side effects.
Ezema Evaristus Chinonye +5 more
doaj +1 more source
Frontiers in Psychiatry, 2022 Intravenous and intranasal ketamine have been shown to be effective therapeutic options in patients suffering from treatment-resistant depression (TRD).
Kazi Hassan +3 more
doaj +1 more source
Use of Meldonium in the Treatment of Patients with Coronary Artery Disease and Concomitant Arterial Hypertension [PDF]
, 2019 Coronary artery disease (CAD) remains one of the leading causes of mortality and disability in Ukraine. Arterial hypertension (AH) is one of the most common diseases and a leading risk factor for coronary artery disease.The aim of the work is to evaluate
Vakaliuk, I. (Ihor) +1 more
core +3 more sources
25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug [PDF]
, 2014 Introduction. The use of novel psychoactive substances (NPSs) has rapidly increased as well as their online availability. The aim of this paper is to provide a comprehensive review of the nature and the risks associated with 25C-NBOMe, which has recently
BERSANI, FRANCESCO SAVERIO +10 more
core +5 more sources
Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations
Pharmaceutics, 2022 Intravenous dexmedetomidine (DEX) is currently approved by the FDA for the sedation of intubated patients in intensive care units to reduce anxiety and to augment postoperative analgesia.
Ayat A. Allam +10 more
doaj +1 more source
Advances in oral transmucosal drug delivery [PDF]
, 2011 Original article can be found at : http://sciencedirect.com/ Copyright ElsevierThe successful delivery of drugs across the oral mucosa represents a continuing challenge, as well as a great opportunity.
Brown, Marc +2 more
core +1 more source
Sublingual dexmedetomidine: An old drug with a new route for agitation
Saudi Journal of AnaesthesiaSublingual dexmedetomidine under the tradename of IgalmiTM is the first and only FDA-approved sedative agent for treating agitation in schizophrenia and bipolar I or II patients.
Konica Chittoria +3 more
doaj +1 more source
Dermoid cyst in the floor of the mouth extending to the submental region: A case report and a review
Dentistry and Medical Research, 2022 Dermoid cysts in the floor of the mouth or submental region are developmental cysts that occur due to the entrapment of the ectoderm between the second and third branchial arch during embryogenesis around 3rd–5th week of intrauterine life.
Mujtaba Bala +4 more
doaj +1 more source
Buprenorphine in Neonatal Abstinence Syndrome. [PDF]
, 2018 Infants exposed in utero to opioids will demonstrate a withdrawal syndrome known as neonatal abstinence syndrome (NAS). Buprenorphine is a long-acting opioid with therapeutic use in medication-assisted treatment of opioid dependency in adults and ...
Kraft, Walter K.
core +1 more source
The challenge of perioperative pain management in opioid-tolerant patients [PDF]
, 2017 The increasing number of opioid users among chronic pain patients, and opioid abusers among the general population, makes perioperative pain management challenging for health care professionals.
Bifulco, F +9 more
core +2 more sources